SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals
INFI 0.0160-4.8%Sep 29 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (66)8/26/2006 2:01:08 PM
From: Mike McFarland  Read Replies (1) of 210
 
heh, I think it is: Every bit of stock action up
until a Novartis milestone, or 609 entering the
clinic is noise. There will be a couple steps
forward, a step back--over and over again. On
balance shares will gradually work there way over
to stronger and stronger hands.

There is a presentation dated August 16th on the
SEC website. Most of it is charts of preclinical
tumor graft experiments and such--I trust that
crap about as far as I can spit. Ten years ago
I was dazzled by Targeted Genetics' presentations
with xenograft lab rats and stuff--maybe a Rick or
a Peter or one of those guys can fine a single slide
that means something to them, not me.

However, the list of venture capitalists I like,
it is a nice reminder of the quality of investors
behind Infinity:

Venture Capitalists •
Prospect Venture Partners •
Venrock Associates •
Advent Venture Partners •
HBM BioVentures •
Vulcan Ventures •
Novartis BioVentures •
Wellcome Trust •
POSCO BioVentures •
Tallwood •
Alexandria Equities •
Lotus BioScience Pharmaceutical Companies •
Amgen •
Novartis •
J&J

Now, does INFI warrant a 300M marketcap when it
starts trading? Maybe, maybe not--anything between
200M and about 500M is fair. But the VC investors
in Infinity surely expect a three to five bagger over
three to five years. I'll ride along with them.

Meanwhile some of the daytraders and swingtraders will
extract a little profit--but only from each other. The
PDUFA type traders will do good, but not necessarily
any better than a buy and hold type. The VC's will sit
back and relax. Probably some of the managment staff
will leak out a few shares to buy tuition and vacations,
but that is noise too.

That said, how nice it is that dpii is above $3!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News